TITLE

COMMENTARY: High-dose statins are cost-effective compared with conventional-dose statins in patients with acute coronary syndromes

AUTHOR(S)
Alter, David A.
PUB. DATE
November 2007
SOURCE
ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p80
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author reflects on the study on cost-efficacy of high-dose statin therapy over conventional-dose statins in patients with acute coronary syndromes (ACSs). He observes variation between the mechanisms of death of ACS and stable vascular disease. He also notices vagueness in the optimal target level for low-density lipoprotein (LDL) cholesterol in ACS. He suggests to prescribe high-dose statins in high-risk stable coronary artery disease (CAD) on the basis of patient risks, and preferences.
ACCESSION #
28019898

 

Related Articles

  • Intensivierte Statintherapien mit Atorvastatin sowie mit Rosuvastatin f�hren zu einem R�ckgang einer Koronarsklerose. Woitzek, Katja // Praxis (16618157);4/4/2012, Vol. 101 Issue 7, p489 

    No abstract available.

  • Niacin Beats Ezetimibe Head to Head. Elliott, William T. // Clinical Oncology Alert;Jan2010 Supplement 2, p1 

    The article reports on a study which found that raising high-density lipoprotein (HDL)-cholesterol (HDL-C) with niacin is more effective than lowering high-density lipoprotein (LDL)-cholesterol (LDL-C) with ezetimibe plus statin in reversing atherosclerosis. The trial involved more than 200...

  • LDL cholesterol levels in patients with coronary artery disease in real word: data from Cardiovascular Registry of Trieste. Cherubini, Antonella; Paolmba, Andrea; Morosin, Marco; Russo, Giulia; Mazzone, Carmine; Fisicaro, Maurizio; Barbati, Giulia; Stellato, Kira; Cioffi, Gianni; Tarantini, Luigi; Pulignano, Giovanni; Cattin, Luigi; Di Lenarda, Andrea // Cardiologia Croatica;May/Jun2014, Vol. 9 Issue 5/6, p247 

    Background: From the literature we know that less than 50% of patients with coronary artery disease (CAD) reaches the target LDL cholesterol <100 mg/dl in clinical practice. The 2012 European Guidelines on Prevention lowers the target to <70 mg/dl in very high risk patients. Methods: We analyzed...

  • High-dose statins are cost-effective compared with conventional-dose statins in patients with acute coronary syndromes.  // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p80 

    The article presents a study on the cost-efficacy of high-dose statin therapy over conventional-dose statin therapy in patients with acute coronary syndromes (ACSs). It mentions the design, setting and intervention for the study. Hypothetical cohorts of 60-year-old patients with ACS or stable...

  • Goals of statin conversion program. Resch, Nina; Ito, Matthew K. // American Journal of Health-System Pharmacy;2/15/2002, Vol. 59 Issue 4, p380 

    Presents correspondence on the issue of statin conversion program. Criticisms over Ito and others' article about the goals of statin conversion program; Resch's study designed to measure the effect of a pharmacist-managed hyperlipidemia clinic on the attainment of low-density-lipoprotein (LDL)...

  • Try low-dose simvastatin in 'statin intolerance'.  // Pulse;5/26/2010, Vol. 70 Issue 18, p9 

    The article discusses a study conducted by Dutch researchers which found that low doses of simvastatin are tolerated by majority of statin-intolerant patients and reduce levels of low-density lipoprotein (LDL).

  • LDL: See how low you can go--without statins. ETINGIN, ORLI R. // Women's Health Advisor;Jun2012, Vol. 16 Issue 6, p1 

    The article focuses on the lowering of low-density lipoprotein (LDL) cholesterol without taking statin.

  • LDL--Lower is Better, But How Low Should We Go? Karpman, Harold L. // Internal Medicine Alert;10/29/2007, Vol. 29 Issue 20, p155 

    Statin therapy in patients with a very low LDL Cholesterol level (ie, less than 60 mg/dL) appears to be safe and is associated with improved survival.

  • Statins and Dyslipidemia: Should we be Looking Beyond LDL? Kuritzky, Louis // Internal Medicine Alert;5/15/2012, Vol. 34 Issue 9, p71 

    The article focuses on the use of statins, cardiovascular agents, in the treatment of dyslipidemia which lowers low-density lipoprotein cholesterol, a major agent in myocardial infarc­tion and stroke.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics